Endo International Ordinary Shares reported $583.27M in Operating Expenses for its first fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Operating Expenses Change
Abbvie ABBV:US $ 11288M 2467M
Aerie Pharmaceuticals AERI:US $ 51.45M 12.03M
Amarin AMRN:US 157.27M 34.34M
Ani Pharmaceuticals ANIP:US $ 86.77M 3.1M
Bristol Myers Squibb BMY:US $ 9.3B 202M
Coherus Biosciences CHRS:US $ 104.16M 43.1M
Eli Lilly And LLY:US $ 5277.9M 127.8M
Heron Therapeutics HRTX:US $ 77.13M 9.25M
Hikma Pharmaceutical HIK:LN 964M 118M
Horizon Pharma HZNP:US $ 787.85M 96.93M
JAZZ PHA JAZZ:US $ 847.33M 121.16M
Lannett LCI:US $ 100.44M 54.15M
Ligand Pharmaceuticals LGND:US $ 57.89M 4.39M
Merk MRK:US $ 9666M 666M
Novartis NOVN:VX 10.86B 895M
Pacira Pharmaceuticals PCRX:US $ 138.18M 2.42M
Perrigo Ordinary Shares PRGO:US $ 1137.9M 85.1M
Pfizer PFE:US $ 15640M 148M
Phibro Animal Health PAHC:US $ 220.42M 10.01M
Revance Therapeutics RVNC:US $ 86.21M 1.27M
Supernus Pharmaceuticals SUPN:US $ 158.7M 8.17M
Takeda 4502:JP 821.95B 52.96B
Teva Pharmaceutical TEVA:IT 4.74B 361M
Xeris Pharmaceuticals Inc XERS:US $ 44.22M 6.92M
Zoetis ZTS:US $ 1.38B 123M